Shi-Long Zhang (Shilong Zhang)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

High Fat Diet Induced

Pulmonary Embolism

Methicillin Resistant Staphylococcus Aureus

Top Venues

Journal of personalized medicine

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhengyan Zhang, Huiling Chen, Jiating Huang, Shi-Long Zhang, Zhanming Li, Chaoyue Kong, Yuqin Mao, Bing Han
Early Administration of Vancomycin Inhibits Pulmonary Embolism by Remodeling Gut Microbiota. Journal of personalized medicine 13 (3) (2023)
Zhengyan Zhang, Huiling Chen, Jiating Huang, Shi-Long Zhang, Zhanming Li, Chaoyue Kong, Yuqin Mao, Bing Han
Early Administration of Vancomycin Inhibits Pulmonary Embolism by Remodeling Gut Microbiota. Journal of personalized medicine 13 (3) (2023)
Zhengyan Zhang, Huiling Chen, Jiating Huang, Shi-Long Zhang, Zhanming Li, Chaoyue Kong, Yuqin Mao, Bing Han
Early Administration of Vancomycin Inhibits Pulmonary Embolism by Remodeling Gut Microbiota. Journal of personalized medicine 13 (3) (2023)
Shi-Long Zhang, Bing Han, Yu-Qin Mao, Zheng-Yan Zhang, Zhan-Ming Li, Chao-Yue Kong, You Wu, Guo-Qiang Chen, Li-Shun Wang
Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice. Gut microbes 14 (1) (2022)
Zhi-Ming Wang, Shi-Long Zhang, Hua Yang, Rong-Yuan Zhuang, Xi Guo, Han-Xing Tong, Yong Zhang, Wei-Qi Lu, Yu-Hong Zhou
Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma. Cancer medicine 9 (10) (2020)
Qian-Wen Rao, Shi-Long Zhang, Meng-Zhou Guo, Fei-Fei Yuan, Jia-Lei Sun, Feng Qi, Li-Shun Wang, Bi-Wei Yang, Jing-Lin Xia
Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma. Cancer medicine 9 (22) (2020)
Shi-Long Zhang, Wen-Rong Wang, Ze-Juan Liu, Zhi-Ming Wang
Marital status and survival in patients with soft tissue sarcoma: A population-based, propensity-matched study. Cancer medicine 8 (2) (2019)